ONE-YEAR EFFECTIVENESS, RETENTION RATE AND SAFETY OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A REAL-LIFE MULTICENTRE STUDY

被引：1
|
作者：
Chimenti, M. S. [1 ]
Fonti, G. L. [1 ]
Conigliaro, P. [1 ]
Sunzini, F. [1 ]
Scrivo, R. [2 ]
Navarini, L. [3 ]
Triggianese, P. [1 ]
Peluso, G. [4 ]
Scolieri, P. [5 ]
Caccavale, R. [6 ]
Picchianti-Diamanti, A. [7 ]
De Martino, E. [1 ]
Salemi, S. [7 ]
Birra, D. [4 ]
Altobelli, A. [2 ]
Paroli, M. [6 ]
Bruzzese, V. [5 ]
Lagana, B. [7 ]
Gremese, E. [4 ]
Conti, F. [2 ]
Afeltra, A. [3 ]
Perricone, R. [1 ]
机构：
[1] Univ Roma Tor Vergata, Rheumatol Allergol & Clin Immunol, Rome, Italy
[2] Sapienza Univ Roma, Reumatol, Dipartimento Med Interna & Specialita Med, Rome, Italy
[3] Univ Campus Biomed Roma, Dept Med, Unit Allergol Immunol & Rheumatol, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli, IRCCS Presidio Columbus, Ist Reumatol & Sci Affini, Rome, Italy
[5] Osped Nuovo Regina Margherita, UOC Med Interna & Reumatol, Rome, Italy
[6] Sapienza Univ Roma, Dipartimento Sci & Biotecnol Med Chirurg, Latina, Italy
[7] Sapienza Univ Rome, St Andrea Univ Hosp, Dept Clin & Mol Med, Rome, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.3777
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0270
引用
收藏
页码：716 / 716
页数：1
相关论文
共 50 条
  • [41] TWO-YEAR RETENTION RATE OF GOLIMUMAB FOR RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS: A RETROSPECTIVE ANALYSIS OF THE ITALIAN LORHEN REGISTRY
    Manara, M.
    Favalli, E. G.
    Caporali, R.
    Puttini, P. Sarzi
    Marchesoni, A.
    Sinigaglia, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 492 - 493
  • [42] Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study
    Ortolan, Augusta
    Lorenzin, Mariagrazia
    Leo, Giovanni
    Pampaloni, Francesca
    Messina, Francesco
    Doria, Andrea
    Piaserico, Stefano
    Ramonda, Roberta
    DERMATOLOGY, 2022, 238 (05) : 897 - 903
  • [43] AQUILA STUDY IN GERMANY - REAL WORLD ADHERENCE AND PERSISTENCE OF SECUKINUMAB TREATMENT IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS - AN INTERIM ANALYSIS
    Kiltz, Uta
    Peterlik, Daniel
    Winkelmann, Veronika
    Tony, Hans-Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1814 - 1815
  • [44] REAL-LIFE EXPERIENCE FOR SECUKINUMAB IN PSORIATIC ARTHRITIS FROM HURBIO-PSA DATABASE
    Bolek, E. C.
    Bilgin, E.
    Yardimci, G. K.
    Farisogullari, B.
    Duran, E.
    Armagan, B.
    Kilic, L.
    Bilgen, S. A.
    Ertenli, A. I.
    Kalyoncu, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1665 - 1666
  • [45] GETTING THE REAL EXPERIENCE: PATIENTS WITH PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED WITH SECUKINUMAB AT THE ARMY HOSPITAL OF SANTIAGO, CHILE
    Grunholz Gambi, Daniela
    Wainstein Gurovich, Eduardo
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S68 - S68
  • [46] Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study
    Erdes, Sh.
    Mazurov, V. I.
    Gaydukova, I. Z.
    Anoshenkova, O. N.
    Vinogradova, I. B.
    Grabovetskaya, Yu. Yu.
    Davidian, S. Y.
    Kiryukhina, N. A.
    Epifanova, O. E.
    Masneva, L. V.
    Menshikova, L. V.
    Mironenko, O. N.
    Nikulenkova, N. E.
    Povarova, T. V.
    Poliatika, A. N.
    Samigullina, R. R.
    Sizikov, A. E.
    Totrov, I. N.
    Umnova, I. F.
    Usacheva, J. V.
    Chudinov, A. L.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2024, 518 (01) : 382 - 392
  • [47] Rituximab retention rate in systemic sclerosis: a long term real-life multicentre study
    De Luca, Giacomo
    De Lorenzis, Enrico
    Campochiaro, Corrado
    Cacciapaglia, Fabio
    Del Papa, Nicoletta
    Zanatta, Elisabetta
    Airo, Paolo
    Lazzaroni, Maria Grazia
    Giuggioli, Dilia
    De Santis, Maria
    Alonzi, Gabriella
    Stano, Stefano
    Binda, Marco
    Moccaldi, Beatrice
    Tonutti, Antonio
    Cavalli, Silvia
    Batani, Veronica
    Natalello, Gerlando
    Iannone, Florenzo
    D'Agostino, Maria Antonietta
    Dagna, Lorenzo
    Matucci-Cerinic, Marco
    Bosello, Silvia Laura
    RHEUMATOLOGY, 2024,
  • [48] LEVETIRACETAM ONE YEAR RETENTION RATE IN REAL-LIFE PRACTICE IN FRANCE, FINAL RESULTS OF THE EULEV STUDY
    Droz, C.
    Dureau, C.
    Vespignani, H.
    Marchal, C.
    Jove, J.
    Moore, N.
    Fourrier-Reglat, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 29 - 29
  • [49] Levetiracetam One Year Retention Rate in Real-Life Practice in France, Final Results of the EULEV Study
    Droz, C.
    Dureau, C.
    Vespignani, H.
    Marchal, C.
    Jove, J.
    Moore, N.
    Fourrier, A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S196 - S197
  • [50] Long-Term Retention Rate of Golimumab in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis in a Real-Life Setting
    Serrano-Benavente, Belen
    Valor, Larissa
    del Rio Blasco, Tamara
    Janta, Iustina
    Gonzalez Benitez, Roberto
    Nieto-Gonzalez, Juan Carlos
    Martinez-Barrio, Julia
    Ovalles Bonilla, Juan Gabriel
    Ariza, Alfonso
    Lopez-Longo, Francisco Javier
    Alvaro-Gracia, Jose Maria
    Monteagudo, Indalecio
    Gonzalez-Fernandez, Carlos Manuel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : E150 - E155
12345